Aims
The ultimate aim is to improve the quality of implementation of drugs
policy in all the participating countries,
with the emphasis on greater awareness of cultural factors influencing
intervention policies.
Target Groups
The network is a co-operation mechanism for professionals working on
the ground: doctors, social workers, representatives of NGOs and public
associations, researchers and policy-makers and
officials. It is geared to promoting interaction between the political,
practical and scientific aspects.
Development and Financing of the network
The network was being developed for a period of one year (2006-2007) after which it was assessed. It was thus recognised as being flexible in terms of functioning and structure and the 2008 activities were pursued under the coordination of the Pompidou Group. The annual report of activities for 2008 confirmed that the flexibility of the functioning was instrumental to the positive results of the network. Funding for the development period was provided by the Netherlands and France.
In 2007, voluntary contributions from Italy, Portugal and Spain were added. Since then, the budget continues to be fed by
voluntary contributions.
Participating countries
The initial focus of the project in 2006 was on North Africa: Algeria, Morocco and Tunisia. In Europe, the partners were France and the Netherlands which
took up where the 1999 Malta initiative - the first conference organised on setting up a co-operation network on drug use in the Mediterranean region - had left off. Since, the
project has been extended and thirteen countries have so far become members.
Lebanon joined the Mediterranean network since January 2007. Italy and Spain joined in June 2007 and Portugal in September 2007. Along with the
representatives of these countries, who must be empowered to commit their national authorities, independent experts are also invited to bring in their knowledge and experience, especially in
the framework of the MedSPAD project (Mediterranean School Survey Project on Alcohol and Other Drugs). Progressively, other countries joined the network: Tunisia in January 2009, Jordan and Egypt in May 2010 and Cyprus in June 2010,
as well as Greece in March 2011.
Member States: Algeria, Cyprus, Egypt, France, Greece, Italy, Jordan, Lebanon, Malta, Morocco, Portugal, Spain, Tunisia.
Added value
- Adaptation to the southern Mediterranean cultural
context of the methodology and tools recognised and
used in Europe
- Wide range of activities whereby qualitative and quantitative information in various fields is collected with a view to a comprehensive approach to the drug problem
- Bridging role between Europe and the southern part of the Mediterranean region
- Exchange of knowledge and experience between the countries of the southern rim of the Mediterranean
- Activities based on needs expressed by stakeholders in the countries concerned
- Instilling of awareness and skills in the drug field through meetings at which various agencies come together
- Flexibility in the implementation of programmes
- Regular and thorough evaluation by all stakeholders
- Cost-effectiveness